Citius Pharmaceuticals, Inc. — Director's Dealing 2019

Oct 10, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Citius Pharmaceuticals, Inc. (CTXR)
CIK: 0001506251
Period of Report: 2019-10-08

Reporting Person: Kane William (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-08	Options to Purchase Common Stock	$0.67	A	25000	Acquired	2029-10-08	Common Stock (25000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to Purchase Common Stock	$1.62	2028-09-04	Common Stock (15000)	15000	Direct
Options to Purchase Common Stock	$3.45	2027-09-13	Common Stock (10000)	10000	Direct
Options to Purchase Common Stock	$0.015	2024-03-28	Common Stock (12071)	12071	Direct
Options to Purchase Common Stock	$12.00	2026-06-23	Common Stock (13334)	13334	Direct

Footnotes

F1: The options vest in full on October 8, 2020.

F2: The options vest in full on September 4, 2019.

F3: The options vest in full on September 13, 2018.

F4: The options vested in 1/3 increments over a three year period with the first installment vesting on March 28, 2015.

F5: The options vested in full on the first anniversary of the date of grant.